Member Biography


Milan Radovich, Ph.D.
Milan Radovich

Milan Radovich, Ph.D.

1030 W. Michigan Street
Suite 3307
Indianapolis, IN 46202
Phone: (317) 948-9516

Research Program Membership

Full member:

Associate Professor
Department of Surgery
Division of General Surgery
IU School of Medicine

Associate Professor
Department of Medical and Molecular Genetics
IU School of Medicine

Associate Professor
Department of Medicine
IU School of Medicine

Dr. Radovich's research interests include:

My research work is focused on the use of genomic technology in translational oncology. My laboratory has performed RNA-sequencing of thymomas to discover a microRNA cluster that overactivates the PI3K pathway (Radovich et al. BJC 2016). This has to led to initiation of a Phase II clinical trial of the PI3K-inhibitor Buparlisib in metastatic thymoma (NCT02220855). Dr. Milan Radovich, PhD is an associate professor at the Indiana University School of Medicine. He is also Vice President for Oncology Genomics at Indiana University Health and co-leads the IU Health Precision Genomics Program, a clinical program dedicated to the integration of cutting-edge genomics for the care of metastatic cancer patients. As an NCI-funded investigator, his research expertise focuses on the use of genomics in translational oncology. In particular, his research concentrates on the use of genomics for precision medicine, clinical trials, genomically-informed drug combinations, circulating biomarkers of cancer detection, companion diagnostics, and novel bioinformatic pipelines for cancer genome analyses. His lab has long standing-expertise in the research of triple-negative breast cancer, thymic malignancies, and cancer precision medicine. As co-director of the IU Health Precision Genomics Program, he helps lead a clinical service line that uses cancer genomics and germline pharmacogenomics to guide therapy for cancer patients. This program has sequenced over 2000 patients to date. With four clinics across the state of Indiana, the program provides access to cutting-edge genomic-based cancer care for patients. Dr. Radovich is passionate about providing the best care to patients through precision medicine. He actively engages with patient advocacy and philanthropic groups to bring genomics research to patients. When he is not in the cancer center or in the lab, he enjoys spending time with his family. As a native Chicagoan and Purdue graduate, he also enjoys cheering on the Bears and Boilermakers.

Importing from PubMed - Please Wait...Importing from PubMed, Please Wait

More Publications »